Breathe Well Live Well
|
Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
Centre Daily Times The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical … |
View full post on asthma – Google News
|
Reportlinker Adds The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016
SYS-CON Media (press release) The global respiratory market was valued at $44.0bn in sales in 2010 with asthma/COPD drugs being the key revenue drivers of the therapeutic segment. Of respiratory indications, asthma represents the main area of R&D interest for pharmaceutical … |
View full post on asthma – Google News
|
Reportlinker Adds U.S. Asthma/COPD Market
PR Newswire (press release) This research service provides an in depth analysis of factors affecting the growth of the US asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, … |
View full post on asthma – Google News
|
Reportlinker Adds the Asthma, COPD & Allergic Rhinitis Market Outlook to 2015
SYS-CON Media (press release) 21, 2010 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global sales of asthma, … |
View full post on asthma – Google News
|
Reportlinker Adds the Asthma, COPD & Allergic Rhinitis Market Outlook to 2015
PR Newswire (press release) 21, 2010 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global sales of asthma, … |
View full post on asthma – Google News